But the standard in medicine is usually to include the drop-outs, raising the bar for new drugs, and this was the analysis pre-specified in the SHARP protocola nd the one Merck presented.
Since these exporters are usually extremely keen to maintain their share in the world's biggest market, they often absorb the effect of a drop in the dollar by cutting their profits rather than raising the price.